Nutlin-3a regulates mouse adipose function by inhibition of CIDEC expression

doi:10.16352/j.issn.1001-6325.2024.02.0154

Basic & Clinical Medicine ›› 2024, Vol. 44 ›› Issue (2): 154-158.doi: 10.16352/j.issn.1001-6325.2024.02.0154

• Original Articles • Previous Articles Next Articles

Nutlin-3a regulates mouse adipose function by inhibition of CIDEC expression

CHEN Enhui^1,2, YANG Jiahui³, ZHAO Wei², XIE Xianghong², GUO Yanfang², LIU Xiaojun², YAN Li^1*

1. Department of Pathophysiology;
2. State Key Laboratory of Common Mechanism Research for Major Diseases, Institute of Basic Medical Sciences CAMS,School of Basic Medicine PUMC,Beijing 100005;
3. Department of Microbiology and Immunology,Basic Medicine College,Shanxi Medical University,Taiyuan 030001, China

Received:2023-09-23 Revised:2023-11-27 Online:2024-02-05 Published:2024-02-05
Contact: ^*yanli@ibms.pumc.edu.cn

Abstract

Abstract: Objective To investigate the effect of Nutlin-3a, a mouse double minute 2 homolog (MDM2) inhibitor, on lipid metabolism of mouse adipose. Methods High-fat diet-induced obesity (DIO) C57BL/6J mice were randomly divided into a control group injected with DMSO and an experimental group injected with Nutlin-3a. Then we conducted glucose tolerance (GTT) and insulin tolerance (ITT) tests. The epididymal white adipose tissue (eWAT), inguinal white adipose tissue (iWAT) and brown adipose tissue (BAT) of animals were isolated and microscopy of WATs with hematoxylin-eosin (HE) staining was performed to observe the morphological changes of adipocytes. The expression of lipid metabolism related gene cell death-inducing DFF45-like effector C (CIDEC) in eWAT were detected by qPCR and Western blot. Results Compared with the control group, Nutlin-3a was found to promote the body weight (P＜0.001),but no effect on glucose tolerance and insulin sensitivity in DIO mice. Nutlin-3a treatment decreased the size of adipocytes and fat deposition in adipose tissue and downregulated the mRNA and protein levels of CIDEC in eWAT. Conclusions Nutlin-3a inhibits the formation of lipid droplets by downregulating expression of CIDEC in white adipose tissue.

Key words: Nutlin-3a, fat metabolism, adipose tissue, CIDEC

CLC Number:

R339.6

CHEN Enhui, YANG Jiahui, ZHAO Wei, XIE Xianghong, GUO Yanfang, LIU Xiaojun, YAN Li. Nutlin-3a regulates mouse adipose function by inhibition of CIDEC expression[J]. Basic & Clinical Medicine, 2024, 44(2): 154-158.

References 12

[1]	Spiegelman BM, Flier JS. Obesity and the regulation of energy balance[J]. Cell, 2001, 104: 531-543.
[2]	Bays HE, Gonzalez-Campoy JM, Bray GA, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity[J]. Expert Rev Cardiovasc Ther, 2008, 6: 343-368.
[3]	Tchkonia T, Morbeck DE, Von Zglinicki T, et al. Fat tissue, aging, and cellular senescence[J]. Aging Cell, 2010, 9: 667-684.
[4]	Barbosa AD, Siniossoglou S. Function of lipid droplet-organelle interactions in lipid homeostasis[J]. Biochim Biophys Acta Mol Cell Res, 2017, 1864: 1459-1468.
[5]	Kohlwein SD, Veenhuis M, van der Klei IJ. Lipid droplets and peroxisomes: key players in cellular lipid homeostasis or a matter of fat--store ‘em up or burn’ em down[J]. Genetics, 2013, 193: 1-50.
[6]	Puri V, Konda S, Ranjit S, et al. Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage[J]. J Biol Chem, 2007, 282: 34213-34218.
[7]	Liang L, Zhao M, Xu Z, et al. Molecular cloning and characterization of CIDE-3, a novel member of the cell-death-inducing DNA-fragmentation-factor (DFF45)-like effector family[J]. Biochem J, 2003, 370: 195-203.
[8]	Liu Z, Jin L, Yang JK, et al. The dysfunctional MDM2-p53 axis in adipocytes contributes to aging-related metabolic complications by induction of lipodystrophy[J]. Diabetes, 2018, 67: 2397-2409.
[9]	Zhao W, Xu Q, Yang J, et al. Murine double minute 2 aggravates adipose tissue dysfunction through ubiquitin-mediated six-transmembrane epithelial antigen of prostate 4 degradation[J]. iScience, 2022, 25: 104544. doi: 10.1016/j.isci.2022.104544.
[10]	Lee J, An S, Choi YM, et al. TRIAD1 is a novel transcriptional target of p53 and regulates Nutlin-3a-induced cell death[J]. J Cell Biochem, 2017, 118: 1733-1740.
[11]	Gao G, Chen FJ, Zhou L, et al. Control of lipid droplet fusion and growth by CIDE family proteins[J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2017, 1862: 1197-1204.
[12]	Toh SY, Gong J, Du G, et al. Up-regulation of mitochondrial activity and acquirement of brown adipose tissue-like property in the white adipose tissue of fsp27 deficient mice[J]. PLoS One, 2008, 3: e2890. doi:10.1371/journal.pone.0002890.

Nutlin-3a regulates mouse adipose function by inhibition of CIDEC expression

PDF

Knowledge

Abstract

Cite this article

share this article

References 12

Related Articles 7

Recommended Articles

Metrics

Comments

[1]	CHEN Xin, CHEN Jun, XU Xing, WANG Xu. Histone demethylase inhibitor GSK-J4 reduces body weight in high-fat diet-induced obese mice [J]. Basic & Clinical Medicine, 2023, 43(9): 1353-1358.
[2]	DU Fenghe, LIU Bao. Research progress on the mechanism of perivascular adipose tissue inflammation promoting atherosclerosis [J]. Basic & Clinical Medicine, 2023, 43(4): 685-689.
[3]	WANG Xueran, TIAN Zongyuan, LIU Ruixia. Research progress on neuregulin 4 regulating lipid metabolism [J]. Basic & Clinical Medicine, 2023, 43(10): 1599-1603.
[4]	YANG Yong, LI Zi-yu, YANG Wei, LIU Yong. Evaluation of inflammation of perirenal adipose tissue in C57BL/6J mice with high-fat diet [J]. Basic & Clinical Medicine, 2021, 41(9): 1318-1322.
[5]	SHU Feng, WANG Meng-yi, ZHANG Shi-wu, LI Qian-zhu, ZHANG Wei-hua. Research progress of inflammatory response of adipose tissue [J]. Basic & Clinical Medicine, 2021, 41(7): 1052-1055.
[6]	ZHANG Wei-hong, ZHAO Wei, LI Chun-mei, XIE Xiang-hong, YAO Hong, LIU Xiao-jun. 4, 4'-Dimethoxy chalcone improves insulin sensitivity of mice in high-fat diet [J]. Basic & Clinical Medicine, 2021, 41(1): 77-81.
[7]	Hua YANG; Zhu-jun SHEN. Adipose Tissue-Derived Cells in Ischemic Heart Disease [J]. Basic & Clinical Medicine, 2010, 30(11): 1226-1229.